Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review

This publication has 38 references indexed in Scilit:

• New Treatment Options for Patients With Metastatic Prostate Cancer: What Is The Optimal Sequence?
  Clinical Genitourinary Cancer, 2015
• Bone Seeking Radiopharmaceuticals for Palliation of Pain in Cancer Patients with Osseous Metastases
  Anti-Cancer Agents in Medicinal Chemistry, 2007
• Natural History and Treatment of Bone Complications in Prostate Cancer
  European Urology, 2006
• Strontium89 Chloride versus Palliative Local Field Radiotherapy in Patients with Hormonal Escaped Prostate Cancer: A Phase III Study of the European Organisation for Research and Treatment of Cancer Genitourinary Group
  European Urology, 2003
• Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer
  British Journal of Cancer, 2001
• Malignant bone pain: Pathophysiology and treatments
  Current Review of Pain, 2000
• Malignant bone pain: pathophysiology and treatment
  Pain, 1997
• A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer
  Radiotherapy and Oncology, 1994
• 89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes
  British Journal of Cancer, 1992
• A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
  European Journal of Cancer and Clinical Oncology, 1991